| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| review article | Q7318358 |
| P2093 | author name string | Li Liu | |
| Shuo Yang | |||
| Shudong Zhou | |||
| Yanhui Gao | |||
| Nana Tian | |||
| Xinqi Lin | |||
| Zhifeng Lin | |||
| Xiaomin Ma | |||
| Junguo Zhang | |||
| P2860 | cites work | Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B | Q58376631 |
| [Relationship between single nucleotide polymorphisms in IL28B gene and response to interferon treatment in chronic hepatitis B patients] | Q83140306 | ||
| Genetic variation in IL28B and spontaneous clearance of hepatitis C virus | Q24596340 | ||
| Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity | Q24642027 | ||
| Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review | Q26745892 | ||
| Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection? | Q26865747 | ||
| Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial | Q28301659 | ||
| IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy | Q29614896 | ||
| Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C | Q29619541 | ||
| Interferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis C. | Q33600034 | ||
| IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. | Q34142463 | ||
| Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level | Q34481474 | ||
| Endpoints of therapy in chronic hepatitis B. | Q37462552 | ||
| IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α. | Q39488926 | ||
| Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B. | Q42228903 | ||
| Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon. | Q42237702 | ||
| IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients. | Q42263099 | ||
| IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B. | Q42979018 | ||
| Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. | Q42996760 | ||
| Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa | Q43279592 | ||
| Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B. | Q44442885 | ||
| Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. | Q46575199 | ||
| Evaluation of susceptibility locus for response to interferon-α based therapy in chronic hepatitis B patients in Chinese. | Q50553933 | ||
| Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma. | Q53211487 | ||
| Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir. | Q54793615 | ||
| The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies | Q56528982 | ||
| Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy | Q57205302 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic hepatitis B | Q55779876 |
| P304 | page(s) | e37534 | |
| P577 | publication date | 2016-06-29 | |
| P1433 | published in | Hepatitis Monthly | Q15734417 |
| P1476 | title | The Role of Interferon Lambda 3 Genetic Polymorphisms in Response to Interferon Therapy in Chronic Hepatitis B Patients: An Updated Meta-Analysis | |
| P478 | volume | 16 |
| Q48100807 | Germline genetic variants with implications for disease risk and therapeutic outcomes | cites work | P2860 |
Search more.